Dusunen Adam-Journal of Psychiatry and Neurological Sciences is a vital resource for scholars and practitioners in the fields of psychiatry and neurology, published by KARE PUBL in Turkey. With an ISSN of 1018-8681 and E-ISSN 1309-5749, this journal has steadily contributed to the academic discourse since its inception, with a dedicated focus on contemporary issues and research findings in psychological and neurological sciences. The journal, which is recognized as Q3 in both the Neurology (clinical) and Psychiatry and Mental Health categories, currently ranks #413 out of 567 in Psychiatry and Mental Health and #298 out of 400 in clinical Neurology according to Scopus. Its commitment to advancing knowledge in these critical areas makes it a significant platform for researchers, professionals, and students alike, fostering a deeper understanding of mental health and neurological disorders that are increasingly relevant in our society. As Dusunen Adam continues to evolve through its convergence years from 2011 to 2024, it remains dedicated to enhancing the quality of life through research and evidence-based practices.

Psychoanalytic Psychotherapy is a distinguished journal published by Routledge Journals, Taylor & Francis Ltd, focusing on the intersection of psychoanalysis and psychotherapy. Established in the United Kingdom and spanning its influential discourse since 1985, the journal has become an essential resource for researchers, clinicians, and students in the fields of Clinical Psychology and Psychiatry and Mental Health. With an impact factor reflecting its critical role in contemporary mental health discussions, Psychoanalytic Psychotherapy is indexed in Scopus and proudly holds a Q3 ranking in both Clinical Psychology and Psychiatry categories. The journal aims to publish cutting-edge research, theoretical advancements, and clinical applications, fostering a deeper understanding of psychoanalytic principles in therapeutic settings. Although it does not offer Open Access, the journal remains crucial for professionals seeking to explore the latest insights and empirical findings in psychoanalytic therapy.

ACTAS ESPANOLAS DE PSIQUIATRIA, published by the renowned JUAN JOSE LOPEZ-IBOR FOUNDATION, serves as a vital resource in the field of psychiatry and mental health, particularly within the Spanish-speaking academic community. With its ISSN 1139-9287 and E-ISSN 1578-2735, this journal has been a critical platform for disseminating high-quality research since its inception in 1996 and continues to contribute valuable insights until 2024. As a recognized journal in the Q3 category of psychiatry and mental health, it ranks 387 out of 567 in Scopus, placing it within the 31st percentile, thereby indicating a growing influence among its peers. The journal’s open access options enhance its accessibility, encouraging a broader readership to engage with contemporary research issues in mental health. Researchers, professionals, and students alike will find ACTAS ESPANOLAS DE PSIQUIATRIA essential for staying informed on the latest developments and innovations in psychiatric practice and research.

SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, published by Springer Heidelberg, is a leading journal in the fields of Epidemiology, Psychiatry, and Mental Health, as well as Social Psychology. With its origins dating back to 1988, the journal remains at the forefront of research, exploring the intricate relationship between social factors and mental health outcomes. The journal boasts impressive rankings, holding Q1 status in multiple categories for 2023, including a notable rank of #22 in the Health (social science) category on Scopus, highlighting its influential role in academia and practice. Although it operates on a subscription-based model, it is widely recognized for disseminating high-quality research, making vital contributions to public health policy and clinical practice. By actively promoting scholarly discourse and interdisciplinary collaboration, SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY serves as an essential resource for researchers, professionals, and students committed to advancing our understanding of the social determinants of mental health.

Welcome to the Spanish Journal of Psychiatry and Mental Health, a leading platform for innovative research and discourse in the fields of psychiatry and mental health. Published by ELSEVIER ESPANA SLU, this peer-reviewed journal serves as a critical resource for clinicians, researchers, and students dedicated to advancing understanding and treatment of mental health disorders. With a commendable ranking of #54 out of 567 in the Psychiatry and Mental Health category according to Scopus, it proudly positions itself in the 90th percentile, reinforcing its significance within the academic community. As an open-access journal, it aims to disseminate high-quality research to a global audience, promoting collaboration and knowledge sharing among mental health professionals. The journal's dynamic publication schedule, covering Converged Years from 2023 to 2024, ensures that it remains at the forefront of mental health scholarship. We invite you to explore the latest findings, engage with thought-provoking articles, and contribute to the ongoing dialogue in this vital discipline.

BMC Psychiatry is a leading open-access journal published by BMC, dedicated to advancing the field of psychiatry and mental health. With its E-ISSN 1471-244X, the journal has been at the forefront of disseminating high-quality research since its inception in 2001, and it proudly maintains a Q1 ranking among psychiatry and mental health journals, reflecting its significant impact and relevance within the research community. Based in the United Kingdom, BMC Psychiatry boasts a commendable Scopus ranking of #158 out of 567 in the psychiatry and mental health category, placing it in the 72nd percentile. The journal serves as a vital platform for scholars, clinicians, and students alike, providing them with access to groundbreaking studies, innovative methodologies, and emerging trends in mental health. By fostering a collaborative environment, BMC Psychiatry not only enriches the academic landscape but also contributes to evidence-based practice and policy in mental health care.

FORUM DER PSYCHOANALYSE, published by SPRINGER, is a distinguished German journal dedicated to the fields of Clinical Psychology and Psychiatry and Mental Health. With an ISSN of 0178-7667 and an E-ISSN of 1437-0751, this journal plays a crucial role in the dissemination of contemporary psychoanalytic theory and practice. Recognized with a Q3 ranking in both Clinical Psychology and Psychiatry and Mental Health for 2023, it serves as a vital resource for researchers and practitioners seeking to explore the intersection of psychoanalytic thought with current clinical practices and mental health paradigms. Since its inception in 1987, FORUM DER PSYCHOANALYSE has provided a platform for rigorous peer-reviewed articles, detailed case studies, and theoretical explorations, fostering a vibrant community of psychoanalysts and mental health professionals. As an essential publication for those engaged in psychoanalytic research and clinical applications, it upholds high scholarly standards while contributing to the ongoing discourse in mental health and psychoanalysis.

Rivista di Psichiatria, published by PENSIERO SCIENTIFICO EDITORE, stands as a significant contributor to the field of Psychiatry and Mental Health since its inception in 1975. With an ISSN of 0035-6484 and an E-ISSN of 2038-2502, this esteemed journal offers a platform for rigorous academic discourse and cutting-edge research, helping to shape contemporary psychiatric practices and theories. Currently holding a Q2 designation in Psychiatry and Mental Health based on the 2023 category quartiles, and ranking #197 out of 567 in Scopus, it reflects a commendable 65th percentile among its peers. The journal welcomes contributions that encompass a broad range of topics related to mental health, encouraging contributions from a multidisciplinary approach, which aids in its goal of advancing the understanding and application of psychiatric science. While it is a traditional journal without Open Access options, access to its valuable content can support researchers, clinicians, and students in their pursuit of knowledge and innovation within the field. Situated in Rome, Italy, at VIA SAN GIOVANNI VALDARNO 8, ROME 00138, the journal continues to enhance its rich legacy, promoting the exchange of ideas and fostering collaboration amongst practitioners and scholars alike.

Psychiatry and Clinical Psychopharmacology, an open-access journal published by AVES since 2017, is dedicated to advancing the fields of psychiatric medicine and psychopharmacology. With an ISSN of 2475-0573 and an E-ISSN of 2475-0581, this journal aims to provide a platform for disseminating innovative research and clinical findings relevant to mental health professionals and researchers. Although it currently holds a Q3 ranking in Pharmacology (medical) and a Q4 ranking in Psychiatry and Mental Health according to the 2023 category quartiles, the journal has established itself as a significant contributor to evolving discussions in these critical fields. Based in the United Kingdom, the journal encompasses diverse topics, ranging from pharmacological treatments to novel therapeutic approaches in psychiatry, thereby appealing to a broad audience of clinicians, scientists, and students. The open-access model ensures that all research is readily available, fostering an environment of collaboration and knowledge-sharing as the journal converges until 2024 to encompass the latest advancements in both pharmacology and clinical psychopharmacology.

Evidence-Based Mental Health is a renowned academic journal focused on the critical intersection of mental health and clinical practice, dedicated to promoting and disseminating evidence-based research within the field of psychiatry. Published by the esteemed BMJ Publishing Group, this journal serves as a vital resource for clinicians, researchers, and students who seek to enhance their understanding and application of mental health research in real-world settings. With a notable Scopus ranking of #11 out of 531 in the category of Medicine: Psychiatry and Mental Health, placing it in the 98th percentile, it is recognized for its impactful contributions to the field. Though access options have transitioned, the journal's commitment to fostering high-quality, peer-reviewed content remains unwavering. As coverage has discontinued in Scopus from 1998 to 2022, the journal continues to gather pivotal insights that aid practitioners in their decision-making processes while addressing contemporary challenges in mental health care.